CHARLOTTE, N.C., Nov. 3, 2026 /PRNewswire/ -- JELD-WEN Holding, Inc. (NYSE: JELD) ("JELD-WEN" or the "Company") today announced results for the three and nine months ended September 26, 2026. Comparability is to the same period in the prior year.

Third Quarter 2026 Highlights

- Net revenues of $798.5 million decreased (1.4%) in the third quarter driven by a decrease in Core Revenues of (1%). The decline in Core Revenues was driven by a (2%) decrease in volume/mix, partially offset by a 1% benefit from price realization.

- Net loss was ($17.2) million or ($0.20) per share, compared to net loss of ($367.6) million, or ($4.30) per share, during the same quarter a year ago. Operating income (loss) margin was 1.1% and (25.0%) for the quarters ended September 26, 2026 and September 27, 2025, respectively.

- Adjusted EBITDA was $54.4 million, an increase of $10.0 million compared to $44.4 million during the same quarter a year ago. Adjusted EBITDA Margin was 6.8%, an increase of 130 basis points in the third quarter primarily due to  tariff refunds recognized as a reduction in cost of sales, favorable productivity, and lower SG&A expense, partially offset by negative price/cost and volume/mix.

- Commenced transactions to extend debt maturities and raise $135.0 million of incremental liquidity.

- Concluded the strategic review of the European business; retaining the business, with a focus on operational improvements and cost reductions, provides the best opportunity to create long-term value.

"Our third-quarter results reflect the continued progress we are making to strengthen our business, even as market conditions remain challenging," said Chief Executive Officer William J. Christensen. "We remain focused on improving service, managing costs, and driving productivity, which are helping us improve our competitive position. Despite a softer market outlook, we are maintaining our full-year revenue and Adjusted EBITDA guidance while making important progress on our strategic priorities, including our debt refinancing and the future of our European business."

Third Quarter 2026 Results

Net revenues decreased ($11.0) million, or (1.4%), to $798.5 million in the three months ended September 26, 2026, from $809.5 million in the three months ended September 27, 2025. The decrease in net revenues was primarily driven by a decrease  in Core Revenues of (1%). The decline in Core Revenues was driven by a (2%) decrease in volume/mix, partially offset by a 1% benefit from price realization.

Net loss was ($17.2) million in the third quarter, compared to a net loss of ($367.6) million in the same period last year. Adjusted Net Income for the third quarter was $4.4 million, an increase of $21.6 million compared to Adjusted Net Loss of ($17.3) million in the same period last year.

Net loss per share for the third quarter was ($0.20), compared to a net loss per share of ($4.30) in the same quarter last year. Adjusted EPS for the third quarter was $0.05, compared to ($0.20) in the same quarter last year. Adjusted EPS for the quarter ended September 26, 2026, excludes net after-tax charges of $21.6 million, or $0.25 per diluted share. Adjusted EPS for the quarter ended September 27, 2025, excludes net after-tax charges of $350.3 million or $4.10 per diluted share. Third quarter 2025 net loss from continuing ops includes $196.9 million non-cash goodwill impairment and $122.3 million tax special items.

Adjusted EBITDA was $54.4 million, an increase of $10.0 million compared to $44.4 million during the same quarter last year. Adjusted EBITDA Margin was 6.8%, an increase of 130 basis points in the third quarter primarily due to tariff refunds recognized as a reduction in cost of sales, favorable productivity, and lower SG&A expense, partially offset by negative price/cost and volume/mix.

On a segment basis for the third quarter of 2026, compared to the same period last year:

- North America - Net revenues decreased ($16.5) million, or (3.0%), to $529.7 million in the three months ended September 26, 2026, from $546.1 million in the three months ended September 27, 2025. The decrease was primarily due to a decrease in Core Revenues of (3%). The decrease in Core Revenues was driven by a (3%) decline in volume/mix due to weakened market demand. Net income was $21.2 million, an increase of $202.4 million year-over-year. Adjusted EBITDA in North America increased $10.7 million, or 28.3%, to $48.3 million in the three months ended September 26, 2026, from $37.7 million in the three months ended September 27, 2025. The increase was primarily due to tariff refunds recognized as a reduction in cost of sales, improved productivity, and lower SG&A, partially offset by unfavorable price/cost and volume/mix.

- Europe - Net revenues increased $5.5 million, or 2.1%, to $268.9 million in the three months ended September 26, 2026, from $263.3 million in the three months ended September 27, 2025. The increase was primarily due to an increase in Core Revenues of 3%, partially offset by an unfavorable foreign exchange impact of (1%). The increase in Core Revenues was primarily driven by a 4% benefit from price realization, partially offset by unfavorable volume/mix of (1%). Net loss was ($6.9) million, an increase of $146.5 million year-over-year. Adjusted EBITDA in Europe decreased ($1.0) million, or (6.5%), to $15.0 million in the three months ended September 26, 2026, from $16.0 million in the three months ended September 27, 2025. The decrease was primarily due to unfavorable price/cost and higher bad debt expense, partially offset by lower salaries and benefits and improved productivity.

Cash Flows

Net cash used in operating activities was ($72.8) million in the nine months ended September 26, 2026, compared to ($37.7) million in the nine months ended September 27, 2025, an increase in cash used of $35.1 million. The change in cash flows from operating activities was primarily attributable to lower earnings, excluding the prior year impact of the $334.6 million non-cash goodwill impairment charge related to our North America and Europe reporting units and the $129.2 million income tax expense due to an increase to valuation allowances on U.S. tax attributes. Changes in our working capital accounts resulted in a $59.6 million unfavorable year-over-year impact. Accounts receivable, net resulted in a ($36.9) million unfavorable impact, primarily due to the timing of revenue recognition and customer collections. Accounts payable resulted in a ($15.1) million unfavorable impact, primarily due to lower inventory purchases and timing of vendor payments. Inventory resulted in a ($7.6) million unfavorable impact, primarily reflecting a decrease in inventory reserves.

Capital expenditures in the nine months ended September 26, 2026, decreased by $46.7 million to $57.2 million, down from $103.9 million in the nine months ended September 27, 2025. Free Cash Flow used in the nine months ended September 26, 2026, was ($129.9) million, compared to Free Cash Flow used in the nine months ended September 27, 2025, of ($141.6) million. This does not include the impact of proceeds of $110.7 million from the court-ordered divestiture of our Towanda facility, which was completed in the first quarter of 2025.

Full Year 2026 Guidance

JELD-WEN is maintaining its 2026 revenue guidance of $3.1 to $3.2 billion. This range reflects a year-over-year decline in Core Revenues of approximately (2%) to (5%), compared to 2025, and a foreign exchange benefit of approximately $50 million. Additionally, the Company continues to expect Adjusted EBITDA to be in the range of $120 to $150 million, reflecting significant cost reductions, partially offset by continued price/cost and volume pressure.

The Company expects 2026 operating cash flow to generate approximately $10 million.

Conference Call Information

JELD-WEN management will host a conference call on November 4, 2026, at 8 a.m. ET, to discuss the Company's financial results. Interested investors and other parties can access the call either via webcast by visiting the Investor Relations section of the Company's website at https://investors.jeld-wen.com, or by dialing 833-461-5787 from the United States or +1-585-542-9983 internationally and using ID 369649160. A slide presentation highlighting the Company's results is available on the Investor Relations section of the Company's website.

For those unable to listen to the live event, a webcast replay will be available approximately two hours following completion of the call. To learn more about JELD-WEN, please visit the Company's website at https://investors.jeld-wen.com.

About JELD-WEN Holding, Inc.

JELD-WEN Holding, Inc. (NYSE: JELD) is a leading global designer, manufacturer and distributor of high-performance interior and exterior doors, windows, and related building products serving the new construction and repair and remodeling sectors. Based in Charlotte, North Carolina, JELD-WEN operates facilities in 14 countries in North America and Europe and employs approximately 13,900 associates dedicated to bringing beauty and security to the spaces that touch our lives. The JELD-WEN family of brands includes JELD-WEN® worldwide, LaCantina® and VPI⢠in North America, and Swedoor® and DANA® in Europe. For more information, visit corporate.JELD-WEN.com or follow us on LinkedIn.

Investor Relations Contact:

James Armstrong

Vice President, Investor Relations

704-378-5731

jarmstrong@jeldwen.com  

Media Contact:

JELD-WEN Holding, Inc.

Sarah Bruner

Senior Director, Enterprise Communications

980-403-4459

SBruner@jeldwen.com  

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.

Community Healthcare Trust Announces Results for the Three Months Ended September 30, 2026

FRANKLIN, Tenn., Nov. 3, 2026 /PRNewswire/ -- Community Healthcare Trust Incorporated (NYSE: CHCT) (the "Company") today announced results for the three months ended September 30, 2026. The Company reported net income for the three months ended September 30, 2026 of approximately $3.1 million, or $0.09 per diluted common share. Funds from operations ("FFO") and adjusted funds from operations ("AFFO") for the three months ended September 30, 2026 totaled $0.54 and $0.58 per diluted common share, respectively.

Highlights Include:

Executing on Strategic Plan

The Company's results for the three months ended September 30, 2026 reflect measurable progress executing the Strategic Plan announced August 4, 2026. Key operational and financial highlights from the second quarter of 2026 to the third quarter of 2026 include total revenue growth of $1.2 million or 4%, leased occupancy growth from 89.8% to 90.1%, and general and administrative expense decline of $0.7 million or 14.3%. On a year-over-year basis, FFO per share increased by $0.04 or 8.0%, while AFFO per share increased by $0.02 or 3.6%.  Additionally, since the close of the second quarter of 2026, the Company has completed $32.3 million in property dispositions to support ongoing strategic capital recycling.

Dividend

On November 3, 2026, the Company's Board of Directors declared a quarterly common stock dividend in the amount of $0.33 per share, payable on November 25, 2026, to stockholders of record as of November 13, 2026. This is the same quarterly common stock dividend amount as the prior quarter.

Items Impacting Our Results

- Net income and FFO for the three months ended September 30, 2026 were impacted by a reduction in deferred compensation expense, included in general and administrative expenses, totaling approximately $0.9 million in the third quarter of 2026 compared to the second quarter of 2026. The decrease in deferred compensation expense was generally due to fully amortized restricted stock awards and forfeited performance-based restricted stock units at June 30, 2026 totaling approximately $1.25 million, offset partially by an increase in amortization due to restricted stock awards and units granted during the third quarter 2026 totaling approximately $0.4 million.

- During the third quarter of 2026, the geriatric behavioral hospital operator, a tenant in six of the Company's properties, paid approximately $0.5 million in rent, an increase of approximately $0.2 million from the second quarter of 2026. The tenant previously signed a Letter of Intent (LOI) in July 2025 to sell its business to a behavioral healthcare provider. The prospective buyer is finalizing legal and business due diligence and drafting definitive purchase agreements, which include new leases for the six hospital properties owned by the Company. While the transaction is progressing, the Company cannot provide assurance regarding the specific timing or the ultimate certainty of the closing.

- During the third quarter of 2026, the Company sold a property, received net proceeds of approximately $0.1 million, and recorded a $0.7 million loss on sale.

- The Company has four properties under definitive purchase agreements, to be acquired after completion and occupancy, for an aggregate expected purchase price of approximately $99.0 million. The Company's expected returns on these investments are approximately 9.1% to 9.75%. The Company anticipates closing on the first of these properties in the fourth quarter of 2026, a second in the first quarter of 2027, and the remaining two between mid-2027 and early 2028; however, the Company cannot provide assurance as to the timing of when, or whether, these transactions will actually close.

- During the third quarter of 2026, the Company did not issue any shares under its ATM program.

- Subsequent to September 30, 2026, the Company sold two properties as part of the Company's capital recycling program for net proceeds totaling approximately $31.5 million. The proceeds are expected to fund acquisitions through like-kind exchange under Section 1031 and to be used for general corporate purposes.

About Community Healthcare Trust Incorporated

Community Healthcare Trust Incorporated is a real estate investment trust that focuses on owning income-producing real estate properties associated primarily with the delivery of outpatient healthcare services in our target sub-markets throughout the United States. As of September 30, 2026, the Company had investments of approximately $1.2 billion in 196 real estate properties (including one property with sales-type leases and two properties classified as assets held for sale). The properties are located in 36 states, totaling approximately 4.5 million square feet in the aggregate.

Additional information regarding the Company, including this quarter's operations, can be found at www.chct.reit. Please contact the Company at 615-771-3052 to request a printed copy of this information.

Cautionary Note Regarding Forward-Looking Statements

In addition to the historical information contained within, the matters discussed in this press release may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are generally identifiable by use of forward-looking terminology such as "believes", "expects", "may", "will," "should", "seeks", "approximately", "intends", "plans", "estimates", "anticipates" or other similar words or expressions, including the negative thereof. Forward-looking statements are based on certain assumptions and can include future expectations, future plans and strategies, financial and operating projections or other forward-looking information. Such forward-looking statements reflect management's current beliefs and are based on information currently available to management. Because forward-looking statements relate to future events, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of the control of Community Healthcare Trust Incorporated (the "Company"). Thus, the Company's actual results and financial condition may differ materially from those indicated in such forward-looking statements. Some factors that might cause such a difference include the following: general volatility of the capital markets and the market price of the Company's common stock, changes in the Company's business strategy, availability, terms and deployment of capital, changes in the real estate industry in general, interest rates or the general economy, adverse developments related to the healthcare industry, changes in governmental regulations, the degree and nature of the Company's competition, the ability to consummate acquisitions under contract, catastrophic or extreme weather and other natural events and the physical effects of climate change, the occurrence of cyber incidents, effects on global and national markets as well as businesses resulting from increased inflation, changes in interest rates, supply chain disruptions, labor conditions, prolonged government shutdown or budgetary reductions or impasses, tariffs and global trade tensions, and/or international conflicts (including the conflicts in the Ukraine and in the Middle East), and the other factors described in the section entitled "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2025, and the Company's other filings with the Securities and Exchange Commission from time to time. Readers are therefore cautioned not to place undue reliance on the forward-looking statements contained herein which speak only as of the date hereof. The Company intends these forward-looking statements to speak only as of the time of this press release and undertakes no obligation to update forward-looking statements, whether as a result of new information, future developments, or otherwise, except as may be required by law.

CONTACT: Bill Monroe, 615-771-3052

SOURCE Community Healthcare Trust Incorporated

Share this article

WASHINGTON, Nov. 3, 2026 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate at the following upcoming investor conferences in November 2026:

The 8th Annual Wolfe Research Healthcare Conference in New York City on Tuesday, November 10, 2026.

The Stifel 2026 Healthcare Conference in New York City on Wednesday, November 11, 2026. A fireside chat is scheduled for 8:40 a.m. Eastern Time.

The Truist Securities 2026 Biopharma Symposium in New York City on Thursday, November 12, 2026.

The UBS Global Biopharma Conference in London on Tuesday, November 17, 2026.

The Jefferies Global Healthcare Conference in London on Thursday, November 19, 2026. A fireside chat is scheduled for 2:00 p.m. Greenwich Mean Time (9:00 a.m. Eastern Time).

The fireside chats at the Stifel 2026 Healthcare Conference and Jefferies Global Healthcare Conference may be accessed live on Vanda's corporate website, www.vandapharma.com. Investors should click on the Investors tab and follow the link under Recent Events. Investors are advised to go to the conference website at least 15 minutes early to register, download, and install any necessary software or presentations. A link to the archived conference will be available on Vanda's website for a period of approximately 30 days.

About Vanda Pharmaceuticals Inc.

Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma.

Corporate Contact:

Kevin Moran

Senior Vice President, Chief Financial Officer and Treasurer

Vanda Pharmaceuticals Inc.

202-734-3400

pr@vandapharma.com

Jim Golden / Jack Kelleher / Dan Moore

Collected Strategies

VANDA-CS@collectedstrategies.com 

SOURCE Vanda Pharmaceuticals Inc.

Share this article

SAN DIEGO, Nov. 3, 2026 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that it will participate at the Stifel 2026 Healthcare Conference, Truist 2026 BioPharma Symposium, UBS Global Biopharma Conference, Jefferies Global Healthcare Conference, and the Piper Sandler 38th Annual Healthcare Conference in November and December.

Details of the company's participation are as follows:

- Stifel 2026 Healthcare Conference

Details: Viking management will participate in a fireside chat and investor meetings.

Conference Dates: November 10-12, 2026

Fireside Chat Date/Time: Wednesday, November 11th, 10:40 am â 11:10 am ET

Location: New York, NY

- Truist 2026 BioPharma Symposium

Details: Viking management will participate in investor meetings.

Conference Date: November 12, 2026

Location: New York, NY

- UBS Global Biopharma Conference

Details: Viking management will participate in a fireside chat and investor meetings.

Conference Dates: November 16-17, 2026

Fireside Chat Date/Time: Tuesday, November 17th, 10:40 am - 11:10 am ET

Location: London, UK

- Jefferies Global Healthcare Conference

Details: Viking management will participate in a fireside chat and investor meetings.

Conference Dates: November 16-19, 2026

Fireside Chat Date/Time: Wednesday, November 18th, 2:00 pm â 2:25 pm GMT

Location: London, UK

Webcast available

- Piper Sandler 38th Annual Healthcare Conference

Details: Viking management will participate in a fireside chat and investor meetings.

Conference Dates: December 1-3, 2026

Fireside Chat Date/Time: Wednesday, December 2nd, 2:00 pm - 2:25 pm ET

Location: New York, NY

Webcast available

A live webcast of the Jefferies and Piper Sandler fireside chats may be accessed via a link on the Viking Therapeutics website in the Investors & Media section under Webcasts. Additionally, a replay of the webcast will be available on the Viking website following the conference.

About Viking Therapeutics, Inc.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company advancing a next-generation portfolio of therapies for obesity and metabolic disease. Guided by deep expertise in metabolic biology and rigorous science, Viking is developing innovative treatments to help people achieve meaningful, lasting health improvements by treating obesity first. The company's lead program, VK2735, is a dual glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist in development in both subcutaneous and oral formulations for obesity. VK2735 is currently being evaluated in Phase 3 clinical studies for obesity, along with maintenance dosing strategies designed to support long-term weight management. Viking is also advancing additional obesity programs, including VK3019, an amylin receptor agonist, VK2809, an orally available thyroid hormone receptor beta agonist for metabolic and liver disease, and VK0214 for the rare genetic disorder X-linked adrenoleukodystrophy (X-ALD).

For more information about Viking Therapeutics, please visit www.vikingtherapeutics.com.

SOURCE Viking Therapeutics, Inc.

Share this article

Third Quarter 2026 total revenue increased 3.0% and comparable store sales increased 1.3%

SUNBURY, Pa., Nov. 3, 2026 /PRNewswire/ -- Weis Markets, Inc. (NYSE: WMK) ("Weis Markets", or the "Company") today reported its financial results for the 13-week third quarter and 39-week year-to-date ended September 26, 2026.

"In the third quarter we delivered higher total revenue and improved earnings while customers remained cautious with their spending and continued to seek affordability and value," said Weis Markets, Inc. Chairman, President and CEO Jonathan H. Weis. "Higher fuel sales, reflecting both retail price inflation and increased gallons sold, along with sales from new stores, supported the quarter's total revenue increase. Inflation Reduction Act-related pharmacy pricing changes, egg price deflation and lower produce demand during the Cyclospora outbreak moderated sales performance. We continue to support our customers through price investments and an expanded loyalty marketing program."

"Improved store inventory shrink performance and lower costs within our internal supply chain helped drive a higher gross profit margin," said Mr. Weis. "Our people, process and technology investments continue to enhance customer value and convenience while supporting greater efficiency across our operations, including stores, supply chain, manufacturing and the Store Support Center. We are grateful to our associates for their commitment to our customers and our business."

Third Quarter 2026 Results

Total revenue was $1.28 billion for the 13-week third quarter ended September 26, 2026, compared to $1.24 billion for the same period in 2025, a 3.0% increase. Sales growth was driven primarily by higher fuel sales and sales from new stores, partially offset by lower overall sales in pharmacy, dairy and produce. Pharmacy sales were negatively impacted by approximately $14.56 million from pricing headwinds related to the Inflation Reduction Act Medicare maximum fair price provisions, which became effective January 1, 2026, reducing total revenue growth by approximately 1.2 percentage points. Dairy sales reflected lower egg pricing compared with the prior year, and produce sales were negatively affected by lower customer demand during the Cyclospora outbreak in the third quarter. Third quarter comparable store sales increased 1.3%, while comparable store sales excluding fuel decreased 1.2%.

Third quarter gross profit increased 5.8% to $324.61 million, and gross profit margin increased to 25.5% from 24.8% in 2025. Income from operations increased 38.6% to $28.51 million. The increase in operating income more than offset lower investment income and a higher effective income tax rate.

The Company's third quarter net income was $22.21 million compared to $16.90 million in 2025, a 31.4% increase. Based on weighted-average shares outstanding, third quarter earnings per share were $0.90 compared to $0.69 per share for the same period in 2025.

Year-To-Date 2026 Results

Total revenue was $3.81 billion for the 39-week year-to-date period ended September 26, 2026, compared to $3.66 billion for the same period in 2025, a 4.1% increase. Sales growth was driven primarily by higher fuel sales and sales from new stores, with grocery and pharmacy sales also increasing compared with the prior year. Despite higher year-to-date pharmacy sales, the category was negatively impacted by approximately $32.75 million from pricing headwinds related to the Inflation Reduction Act Medicare maximum fair price provisions, which became effective January 1, 2026, reducing total revenue growth by approximately 0.9 percentage points. Lower overall sales in dairy and produce also partially offset year-to-date sales growth. Dairy sales reflected lower egg pricing compared with the prior year, and produce sales were negatively affected by lower customer demand during the Cyclospora outbreak in the third quarter. Year-to-date comparable store sales increased 1.9%, while comparable store sales excluding fuel decreased 0.1%.

Year-to-date gross profit increased 7.8% to $983.26 million, and gross profit margin increased to 25.9% from 25.0% in 2025. Income from operations increased 28.6% to $93.31 million. Lower investment income and a higher effective income tax rate moderated the increase in net income.

The Company's year-to-date net income totaled $72.92 million compared to $61.73 million in 2025, an 18.1% increase. Based on weighted-average shares outstanding, year-to-date earnings per share totaled $2.95 compared to $2.38 per share for the same period in 2025.

Quarterly Cash Dividend

On October 29, 2026, the Weis Markets, Inc. Board of Directors declared a quarterly cash dividend of $0.34 per share, payable on November 23, 2026, to shareholders of record as of November 9, 2026.

About Weis Markets

Founded in 1912, Weis Markets, Inc. is a Mid-Atlantic food retailer currently operating 201 stores in Pennsylvania, Maryland, Delaware, New Jersey, New York, West Virginia and Virginia. For more information, please visit: WeisMarkets.com or Facebook.com/WeisMarkets.

In addition to historical information, this news release may contain forward-looking statements, which are included pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected. For example, risks and uncertainties can arise with changes in: general economic conditions, including their impact on capital expenditures; tariffs and trade policies; business conditions and trends in the retail industry; the regulatory environment; rapidly changing technology, including cybersecurity and data privacy risks, and competitive factors, including increased competition with regional and national retailers; price pressures; further expenditures related to restatement of our financial statements; and the results of any shareholder actions associated with the restatements referenced in Note 12 in the Company's Annual Report on Form 10-K filed for the fiscal year ended December 27, 2025. Readers are cautioned not to place undue reliance on forward-looking statements, which reflect Management's analysis only as of the date hereof. The Company undertakes no obligation to publicly revise or update these forward-looking statements to reflect events or circumstances that arise after the date hereof. Readers should carefully review the risk factors described in other documents the Company files periodically with the Securities and Exchange Commission. Management is also providing a two-year stacked comparable store sales analysis, a non-GAAP measure, because Management believes this metric is useful to investors and analysts. It is not recommended that the two-year stacked analysis be considered a substitute for the Company's operating results as reported in accordance with GAAP.

SOURCE Weis Markets

Share this article

CALGARY, AB, Nov. 3, 2026 /PRNewswire/ -- Boardwalk Real Estate Investment Trust (TSX: BEI.UN)

SUMMARY HIGHLIGHTS FOR THE THREE AND NINE MONTH PERIODS ENDED SEPTEMBER 30, 2026

- RESILIENT FINANCIAL PERFORMANCE

FOR THE 3 MONTH PERIOD ENDED SEPTEMBER 30, 2026

- Same Property(1) Occupancy of 97.0% in Q3 2026

- Same Property Rental Revenue growth of 0.9% from Q3 2025

- Same Property Net Operating Income ("Same Property NOI") of $98.2 million; a decrease of 1.1% from Q3 2025

- Net Operating Income ("NOI") of $106.2 million; a decrease of 2.0% from Q3 2025

- Funds From Operations ("FFO") of $1.21 per Unit(2)(3); a decrease of 1.6% from Q3 2025

- Operating Margin of 66.4%; a decrease of 100 basis points ("bps") from Q3 2025; mainly attributable to property tax increase year-over-year

- FOR THE 9 MONTH PERIOD ENDED SEPTEMBER 30, 2026

- Same Property Rental Revenue growth of 1.6% from a year ago

- Same Property NOI of $292.1 million; an increase of 2.0% from the same period a year ago

- Net Operating Income of $319.6 million; an increase of 3.4% from the same period a year ago

- Funds From Operations of $3.54 per Unit; an increase of 2.6% from the same period a year ago

- Operating Margin of 66.0% an increase of 80 bps from the same period a year ago

- THE ALBERTA ADVANTAGE RE-INFORCED AND DE-RISKED

- Recent referendum endorsement for staying in Canada a win-win for Albertans and Canadians to unlock economic growth and energy security

- Demand for apartments remains highest at affordable price points

- Rents in Edmonton, the Trust's largest market, remain some of the most affordable amongst major cities in Canada

- Affordability, economic outperformance and lifestyle continue to support the Alberta Advantage

- TIGHTENING 2026 FINANCIAL GUIDANCE

- FFO range of $4.65 to $4.75 per Unit(2)(3)

- Same Property NOI growth range of +1.0% to +2.0%

- STRATEGIC CAPITAL ALLOCATION

- Subsequent to quarter end, the Trust finalized the sale of three communities in Edmonton, Alberta totaling 536 suites for gross proceeds of $106.5 million (approximately $68.2 million net of existing mortgages)

- During Q3 2026, closed on the previously announced sales of ten non-core communities in London, Ontario, and Grande Prairie, Alberta, totaling 411 suites for gross proceeds of $70.2 million (approximately $40.2 million net of existing mortgages)

- During Q3 2026, closed on the previously announced seed portfolio for strategic co-ownership with DGAM Canadian Private Real Estate Fund, L.P., managed by DGAM Global Asset Management, ("DGAM Real Estate Fund"); sale of 50% interest comprised of 328 suites for gross proceeds of $146.0 million (approximately $86.5 million net of existing mortgages)

- During Q3 2026, the Trust completed its current Normal Course Issuer Bid ("NCIB"); the Trust has invested $262.2 million into the repurchase and cancellation of 4,018,000 Trust Units at a weighted average price of $65.26 since renewal of NCIB in November 2025

- Strategic higher cash positioning for opportunistic deployment in environment that favours community providers with established operating platforms

- EXCEPTIONAL VALUE

- At current unit price of approximately $63, Boardwalk's implied value is approximately $195,000 per suite, equating to an attractive 6.5% cap rate on trailing NOI

- The Trust has cumulatively reinvested in common area improvements representing approximately 74% of its portfolio since 2017, improving portfolio quality and resilience across market conditions

- STRONG AND FLEXIBLE BALANCE SHEET

- Approximately $403.2 million of total available liquidity at the end of the quarter

- 99% of Boardwalk's mortgages carry CMHC-insurance

- Unitholders' Equity of $4.6 billion

- Fair value capitalization rate of 5.22%, an increase of 3 bps from Q4 2025

- Net Asset Value of $96.89 per Unit(2)(3), an increase relative to Q4 2025 and Q2 2026

- Debt to EBITDA(2) of 9.02x, compared to 9.99x for the year ended December 31, 2025

- Debt to Total Assets(2) of 42.7%, compared to 42.3% as at December 31, 2025

- REGULAR DISTRIBUTION OF $1.80 PER TRUST UNIT ON AN ANNUALIZED BASIS CONFIRMED FOR THE MONTHS OF DECEMBER 2026, JANUARY 2027 AND FEBRUARY 2027

Boardwalk Real Estate Investment Trust ("Boardwalk", the "REIT" or the "Trust") today announced its financial results for the third quarter of 2026.

Sam Kolias; Chairman and Chief Executive Officer of Boardwalk REIT commented:

"Boardwalk delivered resilient third quarter results, with Funds From Operations of $1.21 per Unit and Same Property Net Operating Income of $98.2 million, representing slight decreases of 1.6% and 1.1%, respectively, from Q3 2025. We are encouraged to see positive sequential revenue growth during the quarter, which reflects the high demand for affordable housing and the strength of our operating platform. As some of our largest markets are catching up from outsized population growth in recent years, our positive revenue growth was offset by year-over-year increases in property taxes during the quarter. Our focus on retention, service and operational execution has resulted in an improvement in occupancy. Affordability remains central to our value proposition, with Edmonton, our largest market, offering compelling relative value and remaining among Canada's most affordable major rental markets.

Alberta's employment and economic outlook continues to support our confidence in our largest market's medium-term rental housing fundamentals. As we saw in the recent referendum, Albertans voted resoundingly for a win-win outcome that puts Canadian energy and economic growth at the forefront of prosperity for all Canadians. Momentum for building major projects, expanding energy export opportunities and additional investment into various sectors is likely to provide positive drivers for employment and household formation. Together with the affordability and lifestyle advantages of our largest markets, these factors support the ongoing appeal of well-located, high-quality, and affordable rental housing. With higher vacancy rates in the overall market, higher interest rates and lower rents for new construction compared to a couple of years ago, development economics for new supply have become much more difficult.

We continue to pair disciplined capital recycling with accretive unit repurchases and a strong, flexible balance sheet. Our Debt to EBITDA ratio improved to 9.02x during the third quarter, compared to 9.99x at year-end 2025. Our sales throughout the year at full private market values are releasing capital for redeployment. We have successfully redeployed proceeds into our Normal Course Issuer Bid this year, taking advantage of a historically rare opportunity to repurchase our own Units and communities at a sharp discount to their underlying value while contributing positively to our FFO and NAV per Unit. Over the last several years, we have also successfully improved our balance sheet while upgrading the quality of our portfolio through our value-add capital program and selective acquisitions of newer communities that offer rare, highly sought after layouts and value to our Resident Family Members that are difficult to replicate given current development economics. We believe this approach will reward our Unitholders over time as we return to more positive rental housing fundamentals over the medium term.

As we look ahead, we remain focused on sustaining the recent improvement in occupancy, delivering exceptional value to our Resident Family Members and investing our capital in the best opportunities available. The tremendous value proposition of our communities, our one-of-a-kind operating platform and disciplined approach to capital allocation position us to navigate near-term market conditions and create value for all our stakeholders over the medium term."

THIRD QUARTER FINANCIAL HIGHLIGHTS

In Q3 2026, the Trust's same property NOI decreased slightly compared to the same period in the prior year as increased property tax expense more than offset slightly higher same property revenue growth. The Trust remained focused on retention in an environment that continues to reflect temporarily moderated demand in 2026 and 2027 resulting from the federal Immigration Levels Plan released in the fall of 2025.

The Trust's fair value of its investment properties as at September 30, 2026, decreased from year end, primarily attributable to the Trust's dispositions activity year-to-date, as well as to a decrease in market rents in Calgary and a slight increase to cap rates. The Trust's stabilized capitalization rate ("Cap Rate") increased to 5.22% for Q3 2026 compared to 5.19% at year end and decreased slightly compared to 5.25% at Q2 2026, which is mainly the result of the Trust moving its Central Parc Laval property from acquisition price to a stabilized cap rate methodology during the quarter. The Cap Rate ranges utilized continue to be in line with recently published third party quarterly Cap Rate reports.

SOLID OPERATIONAL RESULTS

Total Portfolio Occupancy (1)(2)

Same Property Occupancy (1)(3)

The Trust retained high occupancy during Q3 2026 by focusing on retention and by leveraging its vertically-integrated operating platform to limit the time to complete unit turnovers. The Trust's approach to strategically moderate its lease renewal rates over the last number of years, while markets were heavily undersupplied, has also contributed to maintaining higher occupancy in a more balanced market. Positive market rent adjustments were implemented in some communities where rental market fundamentals were strong. In other communities, market rents were adjusted downward in pockets that have experienced higher deliveries of new supply and where rents were on the higher end of the price spectrum. Overall, demand remains strong for affordable housing. Average occupied rent increased sequentially, and when compared to the same period a year ago.

SAINT PAUL, Minn., Nov. 3, 2026 /PRNewswire/ -- The 3M Board of Directors (NYSE: MMM) today authorized the repurchase of up to $6.0 billion of 3M's outstanding common stock, in addition to the remaining $1.5 billion available under the company's existing 2025 repurchase authorization, resulting in a total of $7.5 billion available under the company's repurchase program. The authorization has no pre-established closing date.

The board also declared a dividend on the company's common stock of $0.78 per share for the fourth quarter of 2026. The dividend is payable Dec. 11, 2026, to shareholders of record at the close of business on Nov. 13, 2026.

3M has paid dividends to its shareholders without interruption for more than 100 years.

About 3M

3Mâ¯(NYSE: MMM) is focused on transforming industries around the world by applying science and creating innovative, customer-focused solutions. Our multi-disciplinary team is working to solve tough customer problems by leveraging diverse technology platforms, differentiated capabilities, global footprint, and operational excellence. Discover howâ¯3Mâ¯is shaping the future atâ¯3M.com/news.

Investor Contact:

Diane Farrow 

612-202-2449 

Media Contact:

3Mnews@mmm.com 

SOURCE 3M Company

Share this article

DENVER, Nov. 3, 2026 /PRNewswire/ -- Gates Industrial Corporation Ltd. (NYSE: GTES), a global manufacturer of innovative, highly engineered power transmission and fluid power solutions, today announced that the Company will participate in the Baird 2026 Global Industrial Conference in Chicago, Illinois on Wednesday, November 11, 2026. Ivo Jurek, Chief Executive Officer, will present at 1:45pm Central time.

To access the webcast of the presentation, please visit the Events & Presentations section of the Gates Investor Relations website at investors.gates.com and click on the event webcast link.

About Gates Industrial Corporation plc:

Gates is a global manufacturer of innovative, highly engineered power transmission and fluid power solutions. Gates offers a broad portfolio of products to diverse replacement channel customers, and to original equipment manufacturers ("OEM") as specified components. Gates participates in many sectors of the industrial and consumer markets. Our products play essential roles in a diverse range of applications across a wide variety of end markets ranging from harsh and hazardous industries to everyday consumer applications including virtually every form of transportation. Our products are sold in more than 130 countries across our three commercial regions: the Americas; Europe, Middle East & Africa; and Asia Pacific.

SOURCE Gates Industrial Corporation Ltd.

Share this article

Ovintiv Reports Third Quarter 2026 Financial and Operating Results

Track Record of Strong Profitability Continues, Significant Additions Made to Premium Return Drilling Inventory

Highlights:

- Generated third quarter net earnings of $549 million, cash from operating activities of $1.1 billion, Non-GAAP Cash Flow of $1.2 billion and Non-GAAP Free Cash Flow of $680 million after capital expenditures of $563 million

- Produced average third quarter volumes of 631 thousand barrels of oil equivalent per day ("MBOE/d"), including oil and condensate volumes of 204 thousand barrels per day ("Mbbls/d"), along with 83 Mbbls/d of other NGLs (C2 to C4) and 2,062 million cubic feet per day ("MMcf/d") of natural gas

- Announced agreement to acquire Logan Energy Corp. for C$1.40 per share in cash for total transaction value of approximately $890 million (C$1.26 billion) including the assumption of Net Debt

- Completed ground game acreage acquisitions in the third quarter totaling $457 million, adding approximately 120 net well locations in Montney, and approximately 120 net well locations in Permian for an average cost of $1.3 million to $1.7 million per 10,000 foot equivalent drilling location

- Net Debt of $3.4 billion as of September 30, 2026, Net Debt to Adjusted EBITDA of 0.7x

- Returned approximately 69% ($467 million) of third quarter Non-GAAP Free Cash Flow to shareholders via share repurchases of approximately $386 million (6.3 million shares) and dividend payments of $81 million

- Full year 2026 shareholder returns expected to exceed 60% of Non-GAAP Free Cash Flow

- Maintained full year 2026 guidance, generating approximately 6% oil and condensate production per share growth over the last six months and on pace for 8% to 9% per share growth by year end

DENVER, Nov. 3, 2026 /PRNewswire/ -- Ovintiv Inc. (NYSE: OVV) (TSX: OVV) ("Ovintiv" or the "Company") today announced its third quarter 2026 financial and operating results. The Company plans to hold a conference call and webcast at 8:00 a.m. MST (10:00 a.m. EST) on November 4, 2026. Please see dial-in details within this release, as well as additional details on the Company's website at www.ovintiv.com under Presentations and Events â Ovintiv.

"Our third quarter results demonstrate the ongoing commitment of our team to create value across the business, and we are on track to achieve record annual free cash flow," said Ovintiv President and CEO, Brendan McCracken. "We have continued to enhance our drilling inventory and future growth optionality in both the Permian and the Montney at an industry leading low-cost per undeveloped location in the core of the best basins. Bolstering our positions in these two basins where we have an operating advantage and demonstrated top performance means we are set to continue delivering superior and durable returns."

Third Quarter 2026 Financial and Operating Results

- Reported third quarter net earnings of $549 million, or $1.99 per share diluted

- Recognized net gains on risk management in revenues of $27 million, before tax

- Generated cash from operating activities of $1.1 billion and Non-GAAP Cash Flow of approximately $1.2 billion

- Third quarter average total production volumes were approximately 631 MBOE/d, including 204 Mbbls/d of oil and condensate, 83 Mbbls/d of other NGLs (C2 to C4) and 2,062 MMcf/d of natural gas

- Third quarter capital investment of $563 million was below the midpoint of the guidance range of $550 million to $600 million

- Reported third quarter upstream operating expense of $3.43 per barrel of oil equivalent ("BOE"), upstream transportation and processing costs of $8.12 per BOE, production, mineral and other taxes of $1.03 per BOE, or 2.7% of upstream product revenue

- Excluding the impact of hedges, third quarter average realized price for oil and condensate was $84.89 per barrel (99% of WTI), $20.26 per barrel for other NGLs, and $2.45 per Mcf (83% of NYMEX) for natural gas, resulting in a total average realized price of $38.10 per BOE

- Including the impact of hedges, third quarter average realized price for oil and condensate was $80.69 per barrel (94% of WTI), $20.26 per barrel for other NGLs, and $2.70 per Mcf (92% of NYMEX) for natural gas, resulting in a total average realized price of $37.56 per BOE

2026 Guidance

The Company issued its fourth quarter 2026 guidance and maintained its full year guidance other than a modest increase to expected NGL volumes. The guidance assumes that an ongoing third-party midstream outage in the Montney persists for the full duration of the fourth quarter.

Shareholder Returns

Ovintiv's shareholder return framework commits to returning 50% to 100% of annual Non-GAAP Free Cash Flow to shareholders via the combination of base dividend payments and share buybacks.

Third quarter shareholder returns totaled approximately $467 million, or approximately 69% of Non-GAAP Free Cash Flow, consisting of share buybacks of approximately $386 million, or approximately 6.3 million shares of common stock, and base dividend payments of approximately $81 million.

As of September 30, 2026, year-to-date shareholder returns totaled approximately $1.1 billion, or approximately 53% of Non-GAAP Free Cash Flow, consisting of share buybacks of approximately $815 million, or approximately 13.9 million shares of common stock, and base dividend payments of approximately $250 million. Ovintiv expects full year 2026 shareholder returns to total more than 60% of Non-GAAP Free Cash Flow.

Continued Balance Sheet Focus

As of September 30, 2026, Ovintiv's Net Debt was $3.4 billion and Net Debt to Adjusted EBITDA was approximately 0.7 times. The Company had approximately $3.8 billion in total liquidity, which included available credit facilities of $3.5 billion, available uncommitted demand lines of $141 million, and cash and cash equivalents of $176 million.

During the quarter, Ovintiv repurchased in the open market approximately $109 million in principal amount of the Company's senior notes.

Dividend Declared

On November 3, 2026, Ovintiv's Board declared a quarterly dividend of $0.30 per share of common stock payable on December 31, 2026, to shareholders of record as of December 15, 2026.

Asset Highlights

Permian

Permian production averaged 235 MBOE/d (77% liquids) in the third quarter with 31 net wells turned in line. Full year 2026 capital investment is expected to total approximately $1.375 billion to $1.425 billion in the play to run approximately 5 rigs and bring on an expected 130 to 140 net wells. In the fourth quarter, oil and condensate production is expected to average approximately 125 Mbbls/d to 130 Mbbls/d and natural gas production is expected to average 300 to 320 MMcf/d.

Montney

Montney production averaged 395 MBOE/d (27% liquids) in the third quarter with 28 net wells turned in line. Full year 2026 capital investment is expected to total approximately $825 million to $875 million in the play to run approximately 6 rigs and bring on an expected 120 to 130 net wells. In the fourth quarter, oil and condensate production is expected to average 75 to 80 Mbbls/d, reflecting lower volumes due to higher than originally expected royalty rates as a result of higher commodity prices, and an extended third-party midstream outage in the play, and natural gas production is expected to average 1.7 to 1.8 billion cubic feet per day ("Bcf/d").

For additional information, please refer to the Third Quarter 2026 Results Presentation available on Ovintiv's website, www.ovintiv.com under Presentations and Events â Ovintiv. Supplemental Information, and Non-GAAP Definitions and Reconciliations, are available on Ovintiv's website under Financial Document Library â Ovintiv.

Conference Call Information

A conference call and webcast to discuss the Company's third quarter 2026 results will be held at 8:00 a.m. MST (10:00 a.m. EST) on November 4, 2026.

To join the conference call without operator assistance, you may register and enter your phone number at https://emportal.ink/4jChvni to receive an instant automated call back. You can also dial direct to be entered to the call by an Operator. Please dial 888-510-2154 (toll-free in North America) or 437-900-0527 (international) approximately 15 minutes prior to the call.

The live audio webcast of the conference call, including slides and financial statements, will be available on Ovintiv's website, www.ovintiv.com under Investors/Presentations and Events. The webcast will be archived for approximately 90 days.

Refer to Note 1 Non-GAAP measures and the tables in this release for reconciliation to comparable GAAP financial measures.

Capital Investment and Production

Third Quarter Financial Summary

Realized Pricing Summary (Including the impact of realized gains (losses) on risk management)

Cost Summary

Debt to EBITDA (1)

Debt to Adjusted EBITDA (1)

Net Debt to Adjusted EBITDA (1)

Hedge Details(1) as of September 30, 2026

Important information

Ovintiv reports in U.S. dollars unless otherwise noted. Production, sales and reserves estimates are reported on an after-royalties basis, unless otherwise noted. Unless otherwise specified or the context otherwise requires, references to "Ovintiv," "we," "its," "our" or to "the Company" include references to subsidiaries of and partnership interests held by Ovintiv Inc. and its subsidiaries.

Please visit Ovintiv's website and Investor Relations page at www.ovintiv.com and investor.ovintiv.com, where Ovintiv often discloses important information about the Company, its business, and its results of operations.

NI 51-101 Exemption

The Canadian securities regulatory authorities have issued a decision document (the "Decision") granting Ovintiv exemptive relief from the requirements contained in Canada's National Instrument 51-101 Standards of Disclosure for Oil and Gas Activities ("NI 51-101").

NEW YORK, Nov. 3, 2026 /PRNewswire/ -- WhiteFiber, Inc. (Nasdaq: WYFI) ("WhiteFiber" or the "Company"), a provider of artificial intelligence infrastructure solutions, today announced that, through its wholly owned subsidiary Enovum Data Centers Corp., it has completed the previously announced acquisition of two industrial properties in Yadkin County, North Carolina, designated NC-2 and NC-3. The purchase price for the properties was $60 million, paid in cash.

Located approximately 55 miles from WhiteFiber's NC-1 campus in Madison, North Carolina, the properties comprise approximately 120 acres of land and 500,000 square feet of existing warehouse space. The properties are expected to provide a combined minimum of 60 megawatts ("MW") of initial gross utility capacity, with the potential to support up to approximately 200 MW within seven years following closing, subject to confirmation and power availability. WhiteFiber intends to retrofit the properties into data center campuses, building on its regional development experience and operating capabilities.

WhiteFiber has received non-binding letters of intent from a broad range of prospective customers for capacity at NC-2 and NC-3 and expansion capacity at NC-1. These include proposals from investment-grade counterparties and proposals incorporating investment-grade credit support. The Company is engaged in advanced discussions with prospective customers across these opportunities.

WhiteFiber is targeting initial ready-for-service capacity at NC-2 and NC-3 in late 2027, subject to customary development conditions. WhiteFiber's development spending plans are expected to be aligned with definitive customer agreements and financing.

In connection with the acquisition, the seller will continue to occupy portions of the properties under occupancy and partial leaseback arrangements. These arrangements are expected to offset a portion of property carrying costs as WhiteFiber advances its development plans.

NC-1 Operational and Financing Update

Switchgear-related commissioning issues interrupted service and billing for the first 20 MW IT data hall and delayed NC-1's ramp to full contracted run-rate billing beyond the previously anticipated August timeframe. Approximately 35 MW of the contracted 40 MW IT deployment is now operational, with work ongoing to bring the remaining 5 MW online.

Capital investment required to deliver the initial contracted deployment is substantially complete, with total development costs currently expected to remain within the Company's initial budget.

WhiteFiber continues to advance financing for the initial contracted deployment at NC-1 with the previously disclosed prospective lending group. The parties are working through the remaining documentation and closing requirements. There can be no assurance that the financing will be completed.

"We are encouraged by the breadth of customer demand, including proposals from investment-grade counterparties and proposals with investment-grade credit support," said Sam Tabar, Chief Executive Officer of WhiteFiber. "We are building on our development and operating experience in North Carolina to meet strong customer demand across our portfolio. Our priority is to turn that demand into long-term contracts and develop capacity with the right customer and financing commitments in place. We look forward to working closely with local stakeholders as we develop these sites and being a responsible long-term partner to the community."

WhiteFiber will report its third-quarter 2026 financial results on November 10, 2026, and provide further financial and operating updates at that time.

About WhiteFiber, Inc.

WhiteFiber is a provider of artificial intelligence ("AI") infrastructure solutions. WhiteFiber owns high-performance computing data centers and provides cloud services to customers. Our vertically integrated model combines specialized colocation, hosting, and cloud services engineered to maximize performance, efficiency, and margin for generative AI workloads. For more information, visit www.whitefiber.com. Follow us on LinkedIn and X @WhiteFiber.

Forward-Looking Statements

This press release may contain forward-looking statements within the meaning of applicable securities laws. Such statements include, but are not limited to, statements about the Company's pursuit and potential completion of financing for the initial contracted deployment at NC-1, including the timing and satisfaction of closing requirements; the Company's ability to bring the remaining MW online;the Company's plans to develop the properties as data center campuses; expected utility capacity and targeted ready-for-service timelines; prospective customer interest and non-binding letters of intent; and the expected benefits of the Company's retrofit-first development strategy, including with respect to time-to-market and capital efficiency. These statements may be identified by words such as "will likely result," "are expected to," "will continue," "will allow us to," "is anticipated," "estimated," "expected", "believe," "intend," "plan," "projection," "outlook" or words of similar meaning. These forward-looking statements are based upon the current beliefs and expectations of the Company's management and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are difficult to predict and generally beyond our control. Actual results and the timing of events may differ materially from the results anticipated in these forward-looking statements.

Actual results, performance or achievements may differ materially, and potentially adversely, from any projections and forward-looking statements and the assumptions on which those forward-looking statements are based. There can be no assurance that the forward-looking statements contained herein are reflective of future performance to any degree. You are cautioned not to place undue reliance on forward-looking statements as a predictor of future performance as projected financial information and other information are based on estimates and assumptions that are inherently subject to various significant risks, uncertainties and other factors, many of which are beyond our control. The Company undertakes no obligation to update any forward-looking statements except as required by law. All forward-looking statements speak only as of the date of this press release.

Investor Contact

WhiteFiber

IR@whitefiber.com

SOURCE WhiteFiber, Inc.

Share this article